Literature DB >> 18827053

Platelets and the antiphospholipid syndrome.

R T Urbanus1, R H W M Derksen, P G de Groot.   

Abstract

The antiphospholipid syndrome is a non-inflammatory autoimmune disease characterised by the presence of antiphospholipid antibodies in the plasma of patients with venous or arterial thrombosis or recurrent complications of pregnancy. The strong relation between the presence of antibodies against anionic phospholipids and thrombo-embolic complications is well established, but how the presence of antiphospholipid antibodies results in the observed clinical manifestations remains a mystery. Experimental observations suggest that an altered regulation of platelet function can cause the thrombotic complications observed in the antiphospholipid syndrome. In this review, we will discuss the evidence that the platelet is an important player in the pathogenesis of the antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18827053     DOI: 10.1177/0961203308096344

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  12 in total

1.  New Insights into the Molecular Basis of the Antiphospholipid Syndrome.

Authors:  Chieko Mineo; Philip W Shaul
Journal:  Drug Discov Today Dis Mech       Date:  2011

2.  Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.

Authors:  Victoria Ulrich; Eddy S Konaniah; Wan-Ru Lee; Sadiksha Khadka; Yu-Min Shen; Joachim Herz; Jane E Salmon; David Y Hui; Philip W Shaul; Chieko Mineo
Journal:  J Am Heart Assoc       Date:  2014-10-14       Impact factor: 5.501

3.  The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome.

Authors:  Joanna Rupa-Matysek; Lidia Gil; Ewelina Wojtasińska; Katarzyna Ciepłuch; Maria Lewandowska; Mieczysław Komarnicki
Journal:  Rheumatol Int       Date:  2014-03-27       Impact factor: 2.631

4.  Protein Phosphatase 2A Activation Via ApoER2 in Trophoblasts Drives Preeclampsia in a Mouse Model of the Antiphospholipid Syndrome.

Authors:  Haiyan Chu; Anastasia Sacharidou; An Nguyen; Chun Li; Ken L Chambliss; Jane E Salmon; Yu-Min Shen; Julie Lo; Gustavo W Leone; Joachim Herz; David Y Hui; Denise K Marciano; Vikki M Abrahams; Bryony V Natale; Alina P Montalbano; Xue Xiao; Lin Xu; David R Natale; Philip W Shaul; Chieko Mineo
Journal:  Circ Res       Date:  2021-08-18       Impact factor: 23.213

Review 5.  Update on Antiphospholipid Syndrome: Ten Topics in 2017.

Authors:  Ilaria Cavazzana; Laura Andreoli; Maarteen Limper; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2018-03-15       Impact factor: 4.592

6.  Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I.

Authors:  Paolo Durigutto; Paolo Macor; Nicola Pozzi; Chiara Agostinis; Fleur Bossi; Pier Luigi Meroni; Claudia Grossi; Maria O Borghi; William Planer; Peter Garred; Francesco Tedesco
Journal:  J Immunol       Date:  2020-08-05       Impact factor: 5.422

7.  Elevated plasminogen activator inhibitor type-1 (PAI-1) as contributing factor in pathogenesis of hypercoagulable state in antiphospholipid syndrome.

Authors:  N K Singh; A Gupta; Dibya R Behera; D Dash
Journal:  Rheumatol Int       Date:  2013-03-22       Impact factor: 2.631

Review 8.  Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.

Authors:  Chieko Mineo
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

9.  Platelets in pulmonary vascular physiology and pathology.

Authors:  Michael H Kroll; Vahid Afshar-Kharghan
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

10.  Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium.

Authors:  Anastasia Sacharidou; Ken L Chambliss; Victoria Ulrich; Jane E Salmon; Yu-Min Shen; Joachim Herz; David Y Hui; Lance S Terada; Philip W Shaul; Chieko Mineo
Journal:  Blood       Date:  2018-03-02       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.